Management of clinical failures in non-ICU patients with chronic obstructive pulmonary disease exacerbations

Chemotherapy

Volumn 47, Issue SUPPL. 4, 2001, Pages 39-46

  Habib, Michael P ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Acute exacerbations; COPD; Fluoroquinolones; Levofloxacin

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BRONCHIECTASIS; CARDIOPULMONARY HEMODYNAMICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; DECISION MAKING; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; MORBIDITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0035743365     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049179     Document Type: Conference Paper

References (11)

1. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease
2. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease
3. Effect of different albuterol dosing regimens in the treatment of acute exacerbation of chronic obstructive pulmonary disease
4. Acute exacerbation of COPD: Factors associated with poor treatment outcome
5. Acute infective exacerbations of chronic bronchitis
6. Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease
7. Infective exacerbations of chronic bronchitis: Relation between bacteriologic etiology and lung function
8. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD
9. Outcome predictors in bronchitis
10. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care
11. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease